Janux Therapeutics (JANX) Gets Initiated With a Buy Rating at Truist Financial
Janux Therapeutics, Inc. (NASDAQ:JANX) is one of the best small cap stocks with the highest upside. Janux Therapeutics, Inc. (NASDAQ:JANX) was initiated with a Buy rating at Truist Financial on October 7. The firm assigned a $100 price target to the stock and cited its proprietary platforms, TRACTr and TRACIr, stating that it believes them […]